There is an argument circulating that Donald Trump is at least not bought by the pharmaceutical industry and that, thus, this somehow makes him immune to being influenced by pharma. But remember that Trump has been in the private sector all of his life and has not been in a position to be lobbied by pharma or any other industry. It is unclear whether he would accept money from pharma as a publicly elected official. What we do know is that Trump owns (or has owned) stock in pharmaceutical industry companies such as Gilead Sciences, Johnson and Johnson, Celgene, McKesson, and Bristol-Myers Squibb. So he does have financial interests in pharma, although, from what I can tell, not significant (given his apparent wealth). So, we’ll have to decide for ourselves on the difference between being “bought by” pharma or “buying into” pharma”.
The difference between being “bought by” pharma or “buying into” pharma